Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice (Q40227882)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 September 2006

Language	Label	Description	Also known as
English	Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice	scientific article published on 11 September 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Mycobacterium tuberculosis

0 references

author name string

Zhengjun Yi

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Yurong Fu

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Chun Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Junming Li

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Xudong Luo

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Quan Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Wei Zeng

7

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Shan Jiang

8

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ying Jiang

9

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Yonglin He

10

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Jian Yang

11

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Yehua Liu

12

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Na Li

13

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Dao-Yin Zhu

14

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

11 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

638-648

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Induction of CD69 expression and Th1 cytokines release from human peripheral blood lymphocytes after in vitro stimulation with Alloiococcus otitidis and three middle ear pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

An antimicrobial activity of cytolytic T cells mediated by granulysin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Broad-Spectrum Antimicrobial and Antibiofilm Activity of a Natural Clay Mineral from British Columbia, Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Close apposition of dynorphin-positive nerve fibres to lymphocytes in the liver suggests opioidergic neuroimmunomodulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Review: the immune response in human tuberculosis--implications for tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Modulation of the immune system by Listeria monocytogenes-mediated gene transfer into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Granulysin, a T cell product, kills bacteria by altering membrane permeability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Granulysin in human serum as a marker of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Acholeplasma laidlawii up-regulates granulysin gene expression via transcription factor activator protein-1 in a human monocytic cell line, THP-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

Mycobacterium marinum persists in cultured mammalian cells in a temperature-restricted fashion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.08.037

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40227882&oldid=1889390565"